Skip to main content
. 2020 Oct;9(5):1628–1638. doi: 10.21037/gs-2019-catp-26

Table 7. ThyroSeq v3: common genomic alterations and probability of cancer or NIFTP (27).

Genomic Alterations Probability of cancer or NIFTP
PTEN ~5–10%
RAS alone 40–80%
Gene expression alteration 50–80%
THADA/IGF2 BP3 alone 50–80%
Copy number alterations 60–70%
RAS and other mutation(s) except TERT 70–80%
PAX8/PPARG alone 50–90%
TERT with or without other mutations 80–95%
RET/PTC alone 95%
BRAF V600E alone 99%
Others 30–95%